We are live on ! Find out more
INDP icon

Indaptus Therapeutics
INDP

33 hedge funds and large institutions have $4.08M invested in Indaptus Therapeutics in 2019 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

58% more call options, than puts

Call options by funds: $76K | Put options by funds: $48K

13% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 8

30% less funds holding

Funds holding: 47 → 33 (-14)

50% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 22

92% less capital invested

Capital invested by funds: $49.4M → $4.08M (-$45.3M)

Holders
33
Holders Change
-14
Holders Change %
-29.79%
% of All Funds
0.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
7
Reduced
8
Closed
22
Calls
$76K
Puts
$48K
Net Calls
+$28K
Net Calls Change
+$2.72M

Top Buyers

Rank Fund Capital Flow
1
TFCM
Taylor Frigon Capital Management
Arizona
+$551K
2
VF
Virtu Financial
New York
+$176K
3
Citadel Advisors
Citadel Advisors
Florida
+$113K
4
AIM
ARK Investment Management
Florida
+$86.3K
5
ARTA
A.R.T. Advisors
New York
+$62.5K

Top Sellers

Rank Fund Capital Flow
1
SAM
Sectoral Asset Management
Quebec, Canada
-$3.81M
2
ACA
Avoro Capital Advisors
New York
-$3.56M
3
PM
Prosight Management
Texas
-$3.54M
4
MIFH
Migdal Insurance & Financial Holdings
Israel
-$3.17M
5
SFM
Sphera Funds Management
Israel
-$2.69M
Name Holding Trade Value Shares
Change 		Change in
Stake
PCM
26
Prelude Capital Management
New York
$5K -$80.4K -27 -90%
FANJ
27
Financial Architects (New Jersey)
New Jersey
$4K – – –
RFA
28
Reilly Financial Advisors
California
$4K – – –
Wells Fargo
29
Wells Fargo
California
$4K +$5.95K +2 New
RE
30
RBC Europe
United Kingdom
$2.88K +$2.98K +1 +100%
BlackRock
31
BlackRock
New York
$1K – – –
CG
32
Cutler Group
California
$1K – – –
RIA
33
Realta Investment Advisors
Delaware
$1K – – –
Royal Bank of Canada
34
Royal Bank of Canada
Ontario, Canada
$1K – – –
UBS Group
35
UBS Group
Switzerland
$1K – – –
SAM
36
Sectoral Asset Management
Quebec, Canada
– -$3.81M -392 Closed
ACA
37
Avoro Capital Advisors
New York
– -$3.56M -366 Closed
PM
38
Prosight Management
Texas
– -$3.54M -364 Closed
MIFH
39
Migdal Insurance & Financial Holdings
Israel
– -$3.17M -326 Closed
SFM
40
Sphera Funds Management
Israel
– -$2.69M -277 Closed
Mirae Asset Global Investments
41
Mirae Asset Global Investments
South Korea
– -$2.53M -260 Closed
DCM
42
DAFNA Capital Management
California
– -$1.8M -186 Closed
EIM
43
Essex Investment Management
Massachusetts
– -$1.23M -127 Closed
DMK
44
David M. Knott
– -$1.13M -116 Closed
Renaissance Technologies
45
Renaissance Technologies
New York
– -$593K -61 Closed
Squarepoint
46
Squarepoint
New York
– -$577K -59 Closed
Deutsche Bank
47
Deutsche Bank
Germany
– -$308K -32 Closed
Millennium Management
48
Millennium Management
New York
– -$174K -18 Closed
JP Morgan Chase
49
JP Morgan Chase
New York
– -$125K -13 Closed
Dimensional Fund Advisors
50
Dimensional Fund Advisors
Texas
– -$108K -11 Closed
1
2
3

INDP Hedge Fund Activity: Q3 2019 in Review

33 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Indaptus Therapeutics (INDP) for Q3 2019, worth a combined $4.08M — down 92% from $49.4M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of INDP and 11 opened new positions — a net loss of 11 holders — while 8 trimmed existing stakes and 7 added.

The largest buyer was Taylor Frigon Capital Management, opening a new position worth an estimated $551K. The largest seller was Sectoral Asset Management, exiting entirely with an estimated $3.81M sold.

  • 33 institutional investors held Indaptus Therapeutics (INDP) as of Q3 2019, down from 47 in Q2 2019.
  • Funds reported $4.08M of Indaptus Therapeutics stock for Q3 2019, down 92% quarter-over-quarter.
  • 11 funds opened new Indaptus Therapeutics positions in Q3 2019 and 22 closed out, a net change of -11 holders.
  • The largest Indaptus Therapeutics buyer in Q3 2019 was Taylor Frigon Capital Management, an estimated $551K added.
  • The largest Indaptus Therapeutics seller in Q3 2019 was Sectoral Asset Management, an estimated $3.81M sold.

Based on aggregated 13F filings for Q3 2019.